New Zealand markets open in 3 hours 22 minutes
  • NZX 50

    -59.79 (-0.54%)

    -0.0016 (-0.26%)

    -75.50 (-1.09%)
  • OIL

    -1.51 (-1.35%)
  • GOLD

    -1.40 (-0.08%)

scPharmaceuticals to Present at the Jefferies Healthcare Conference

·1-min read
scPharmaceuticals, Inc.
scPharmaceuticals, Inc.

BURLINGTON, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the Jefferies Healthcare Conference on Thursday, June 9 at 2:00pm EDT at the Marriott Marquis in New York City.

A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website,

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706

Hans Vitzthum
LifeSci Advisors, 617-430-7578

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting